Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research and Treatment
Published in: Breast Cancer Research and Treatment 2/2015

01-06-2015 | Retracted Article

RETRACTED ARTICLE: Enhancement of doxorubicin efficacy through suppression of serine synthesis in triple-negative breast cancer

Authors: Feng Wang, Yong Yang

Published in: Breast Cancer Research and Treatment | Issue 2/2015

Login to get access

Excerpt

This article has been retracted at the request of the corresponding author due to submission of his article for publication without internal review and approval from his institution (Houston Methodist Research Institute). …
Metadata
Title
RETRACTED ARTICLE: Enhancement of doxorubicin efficacy through suppression of serine synthesis in triple-negative breast cancer
Authors
Feng Wang
Yong Yang
Publication date
01-06-2015
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 2/2015
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-015-3274-x

Other articles of this Issue 2/2015

Breast Cancer Research and Treatment 2/2015 Go to the issue

Letter to the Editor

Interpretation of genomic variation and disease association: the great missense mutation challenge!

Preclinical study

AroER tri-screen™ is a novel functional assay to estimate both estrogenic and estrogen precursor activity of chemicals or biological specimens

Review

Predictive factors of nipple involvement in breast cancer: a systematic review and meta-analysis

Epidemiology

Body mass index associated with genome-wide methylation in breast tissue

Preclinical Study

miR-218 targets survivin and regulates resistance to chemotherapeutics in breast cancer

Review

Incidental primary breast cancer detected on PET–CT
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits